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ABSTRACT
Detrusor underactivity (DU) increases susceptibility to urinary retention and accordingly
further complicates the management of urinary incontinence. Bladder muscle stretch, a lack of
estrogen, and aging are 3 notable DU risk factors. The aim of this research is to better
characterize the changes in cellular composition of the bladder that result from these 3 risk
factors to gain a better understanding of DU pathogenesis and pathobiology. This research
focuses on the effects of a lack of estrogen while also providing an outline for determining the
effects of bladder muscle stretch and aging on the cellular composition of the bladder.
5 transgenic mice underwent bilateral ovariectomy and 2 sham control animals were
established. The mice exhibited endogenous fluorescence for collagen 3.6 and alpha smooth
muscle actin (α-SMA) and antibodies were used to detect vimentin and calponin. 1 week post
surgery, decreased expression of α-SMA and calponin revealed a loss of smooth muscle and a
more pronounced decrease in calponin expression compared to α-SMA expression suggested that
following ovariectomy the smooth muscle transitions to a less mature smooth muscle cell (SMC)
phenotype.
Further studies are needed to better characterize both the endogenous fluorescence in
transgenic mice and the changes in cellular composition of the bladder in DU pathogenesis and
pathobiology.
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INTRODUCTION
The detrusor muscle is made of smooth muscle and constitutes a layer of the urinary
bladder wall. Detrusor underactivity (DU) is defined as, “a contraction of reduced strength
and/or duration, resulting in prolonged bladder emptying and/or a failure to achieve complete
bladder emptying within a normal time span” [1]. DU increases susceptibility to urinary
retention and accordingly further complicates the management of urinary incontinence. Like
urinary incontinence, DU is especially common in geriatric populations. Moreover, although
other risk factors exist, bladder muscle stretch, a lack of estrogen, and aging are 3 notable risk
factors and their effects interact through a common pathway.
Useful animal models exist for all 3 of these notable DU risk factors. Partial bladder
outlet obstruction (pBOO) surgery has been used as an animal model for DU in mice with the
characteristic symptoms of sarcopenia and fibrosis being reproducibly achieved 3 weeks
following surgery [1]. Similarly, bilateral ovariectomy provides a useful animal model for a lack
of estrogen. When using animal models to investigate aging, it is important to include multiple
age groups that are neither too young nor too old [2]. Furthermore, care must be taken to ensure
and provide evidence that aged animals are pathogen free.
The aim of this research is to characterize the changes in the cellular composition of the
mouse bladder that result from DU by examining the changes in cellular composition due to
muscle stretch, lack of estrogen, and aging. Although smooth muscle predominates, the bladder
also comprises other tissue types, including epithelial, nervous, macrophages, and connective.
DU is characterized by changes in these tissues involving bladder muscle loss (sarcopenia),
fibrosis, and axonal degeneration [3].
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Many cell types retain some level of plasticity, allowing them to modify their phenotypes
in response to environmental changes and genetic programs. SMCs exhibit significant plasticity,
allowing them to both quickly and reversibly change phenotype in response to environmental
cues [4]. Different SMC phenotypes correspond to different SMC functions throughout
development, tissue repair, and disease [4]. Additionally, a unique set of marker proteins are
characteristic of each phenotypic state. The expression of marker proteins in SMC
differentiation and maturation can be considered along a continuum in which marker proteins of
less differentiated SMC are first expressed in earlier developmental stages while marker proteins
of more mature SMCs are expressed in later stages of SMC development. Although this
continuum of SMC development was traditionally interpreted as signifying that all mature SMCs
developed from the least differentiated SMCs, a recent study suggests that SMC precursors give
rise to naïve SMCs, which have a synthetic phenotype, but then give rise to a variety of SMC
phenotypes along the continuum [5]. As in the earlier perspective of SMC development, this
new model also recognizes the high degree of plasticity exhibited by SMCs. Furthermore,
investigations of the SMC phenotypic diversity recognized contractile and synthetic SMCs as
being at opposite ends of the SMC phenotypic spectrum [5]. Contractile SMCs are elongated,
spindle-shaped, and contain many contractile filaments [5]. Synthetic SMCs are less elongated,
contain many organelles needed for protein synthesis, and have higher growth rates as well as
greater migratory activity. Contractile and synthetic SMCs, as well as the various intermediate
SMC phenotypes, can be distinguished with marker proteins.
In the presented research, changes in the smooth muscle of the mouse bladder due to
bladder muscle stretch and a lack of estrogen are monitored by observing changes in the relative
numbers of cells expressing α-SMA and calponin following pBOO or bilateral ovariectomy.

7
αSMA is a commonly used marker protein for less differentiated SMCs whereas calponin is
expressed in more mature SMCs [4]. Following one of the prescribed treatments, an increase in
the number of SMCs expressing αSMA and a decrease in those expressing calponin would
indicate that the smooth muscle tissue became less differentiated, towards a synthetic phenotype,
which characterizes sarcopenia and would be expected following bladder muscle stretch, a lack
of estrogen, or aging.
Similar to SMCs, fibroblasts also exhibit significant plasticity and are monitored in this
research by observing the changes in the relative numbers of cells expressing 2 marker proteins,
collagen 3.6 and vimentin. Increases in both marker proteins are characteristic of fibrosis and
therefore expected following bladder muscle stretch, a lack of estrogen, or aging. Figure 1
provides a summary of the expected changes in all 4 examined marker proteins following each
treatment.

Figure 1. Proposed Changes in Bladder Composition with Injury.
Studies suggest that following partial bladder outlet obstruction (pBOO), there is
initially a period of hypertrophy preceding the muscle atrophy and fibrosis that is
observed in longer-term studies
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This research is important as it could increase our limited understanding of DU
pathophysiology and pathogenesis, which will allow for the development of more effective,
rather than simply palliative, treatments for urinary incontinence. Currently, urinary
incontinence in the frail elderly is treated mostly with behavioral therapies while research on
treatment options remains limited [6]. On a broader scale and by considering the general
simplicity of the bladder, this research may contribute to the understanding of other geriatric
problems by serving as a model for a better understanding of both pathogenesis and treatment in
more complex tissues.

MATERIALS AND METHODS
Animal care. Double transgenic mice with fluorescent markers for αSMA (mcherry, red)
and 3.6 collagen (cyan, blue) were obtained from the lab of Dr. Ivo Kalajzic at the University of
Connecticut Health Center. These mice were then bred and maintained in accordance with the
National Institute of Health guidelines. A local animal care committee approved all procedures
and the mice were allowed ad libitum access to food and water.
Animal surgeries. All surgeries were performed on 5 wk old female mice. 5 mice
underwent bilateral ovariectomies. 7 mice underwent partial bladder outlet obstruction (pBOO)
as previously described [1], of which 2 died after surgery. Following both surgeries, mice were
sacrificed 1 week post surgery. Similarly, sham controls were established for both surgeries, 2
for ovariectomies and 4 for pBOO.
Tissue collection and dissociation. Mice were euthanized with isofluorane. After rinsing
the abdomens with ethanol, the bladders were immediately extracted, blotted dry, and placed in
cold PBS solution. In sterile conditions, the bladders were finely minced with a scalpel and razor
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blade and then introduced to filtered dissociation buffer (collagenase P in PBS with a final
concentration of 1 mg/mL passed through a 0.2 µm filter). Following trituration through the firepolished tip of a Pasteur pipette, the samples were placed in a 37°C shaker for 45 min. An equal
volume of trypsin was then added to each sample and the reaction was allowed to continue for 5
min in a 37°C water bath. During this time, the samples were shaken twice. The reactions were
stopped by adding 10% FBS. Next, samples were passed through a 70 µm filter and centrifuged
at 1500 rpm for 5 min. The obtained pellet was re-suspended in 8 mL of wash buffer (10% FBS
in PBS) and centrifuged as before. The pellet was re-suspended in 1 mL of medium
(DMEM/F12 with 10% FBS+P/S, 50x dilution). Cell count was then ascertained using a drop of
this suspension and Trypan blue under 10x magnification.
Sample preparation for FACS analysis. Samples were prepared for FACS analysis in one
of 2 ways, depending on whether or not antibodies were incorporated into the sample analysis.
The first method, for fluorescent samples for which antibodies were not incorporated, involved
first washing the cells 2 times with FACS buffer (into a 1.5 mL tube and adding 1.2 mL FACS
buffer). The samples were then centrifuged at 1300 rpm for 5 min at 4°C. 500 µL of FACS
buffer was added to the obtained pellets and after mixing by vortexing, the samples were ready
for FACS analysis.
The second FACS preparation method, for samples analyzed with antibodies, involved
first following the above procedure for samples not incorporating analysis with antibodies.
These samples were then fixed by adding 150 µL fixing buffer, vortexing, and waiting 30 min.
The antibodies were then introduced as described below. Next, the samples were washed with
500 µL FACS buffer, centrifuged as before, and the obtained pellet mixed with 500 µL FACS
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buffer via vortexing. Unlike the unfixed samples, these samples could be stored at 4°C and did
not need to immediately undergo FACS analysis.
Immunohistochemistry. Monoclonal antibodies against vimentin and calponin were
obtained from Abcam (ab8978) and Sigma (C2687) respectively. Monoclonal antibody labeling
kits were obtained from Invitrogen and used to conjugate vimentin and calponin to the
fluorophores Alexa Fluor 647 and Pacific Blue respectively. The conjugated antibodies were
introduced to the fixed cells by first permeabilizing the cells with permeabilization buffer
(eBioscience) and then incubating the permeabilized cells on ice with the antibodies for 25 min.
Tissue characterization. FACS analysis was used to analyze all samples. The efficacy of
the transgenic markers cherry and cyan, for αSMA and collagen 3.6 respectively, was tested by
comparing the cherry and cyan signals for wild type, cyan only, cherry only, and double
transgenic mice. This analysis was performed using the FACSAria machine.
The efficacy of staining with fluorophore conjugated antibodies against vimentin and
calponin was assayed by comparing the Alexa Fluor and Pacific Blue signals for cell samples
treated with the antibodies to unstained cells. This analysis was performed using the LSR II
machine.
The changes in bladder cellular composition following ovariectomy and pBOO were
investigated by comparing the signals from the 4 markers for αSMA , collagen 3.6, vimentin, and
calponin, between the mice that had undergone ovariectomy or pBOO and their corresponding
sham controls. All mice were double transgenic and the FACSAria machine was used.

RESULTS
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The fluorescence of both cyan and cherry in the untreated double transgenic mouse was
comparable to the corresponding fluorescence in each of the single transgenic controls, showing
that neither signal is disrupted in the double transgenic control (Figure 2). For example, 16.1 +
0.51 = 16.61% of cells in the cyan only control expressed cyan whereas 6.42 + 9.18 = 15.6% of
cells in the double transgenic mouse expressed cyan. Additionally, 9.18% of cells in the double
transgenic bladder expressed both cyan and cherry and are therefore considered myofibroblasts.

Figure 2. Efficacy of Cherry and Cyan Markers
This data was obtained from the FACSAria machine and shows that cherry and cyan are
suitable markers for α-SM actin and collagenase 3.6 respectively in the double transgenic
mouse model.

Following cell fixation, nearly a 50% reduction in the endogenous fluorescence of the
transgenic fluorophores was obtained. This is evident in Figure 3, which shows cherry
expression in the double transgenic mouse before fixing, 9.18 + 32 = 41.18%, and after fixing,
21%.
Figure 3. Changes in
Cherry Fluorescence
when Cells are Fixed
The cherry signal of 2
double transgenic mice
is compared and shows
that fixing the cells
reduces the endogenous
cherry fluorescence by
approximately 50%, from
41.18% to 21%. SSC-A
refers to side scatter.
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Cells from double transgenic mice were stained with antibodies against vimentin and
calponin. The anti-calponin antibody is conjugated to the Pacific Blue fluorophore. In Figure 4,
the no staining sample shows that there is a small amount of overlap between the signals for
collagen 3.6 (cyan) and calponin, which is why the Pacific Blue label is retained throughout the
figure. However, the overlap is only 1.75% and accordingly is not considered significant.
Overall, it is evident that 1 week post ovariectomy, the percentage of cells stained for calponin
decreases, 5.13 + 50.2 = 55.23% compared to 7.25 + 60.3 = 67.55%. A small decrease is also
observed in vimentin, 10.6 + 50.2 = 60.8% compared to 4.36 + 60.3 = 64.66%.

Figure 4. Double Staining and Cellular Composition Changes in the Bladder with Ovariectomy
1 week post ovariectomy, there is a significant decrease in calponin expression and slight decrease in
vimentin expression.

Due to the overlap between the cyan and Pacific Blue, the fluorophores for collagen 3.6
and calponin respectively, the changes in cyan expression 1 week post ovariectomy could be not
ascertained. Given the relatively minor contribution of endogenous cyan to the Pacific Blue
signal (Figure 4: No Staining), the overlap is not considered to significantly impact the calponin
expression as determined by the Pacific Blue signal. The changes in αSMA, calponin, and
vimentin expression following ovariectomy can therefore be ascertained and are illustrated in
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Figure 5. 1 week post ovariectomy, significant decreases in expression are observed in αSMA
(14.7% compared to 21%) and calponin (52.9 + 29.9 = 82.8% compared to 51.7 + 40.2 = 91.9%)
while a slight increase is observed in vimentin expression (1.78 + 52.9 = 54.68% compared to
0.36 + 51.7 = 52.06%)
Similar changes in protein expression, that being decreases in αSMA and calponin
expression accompanied by an increase in vimentin expression, are expected to also occur with
pBOO.
Figure 5. Changes in Cellular
Composition of the Bladder
with Ovariectomy
Overall, 1 week following
ovariectomy, decreases in cherry
fluorescence (corresponding to
αSMA expression) and calponin
expression are observed. The
above Pacific Blue expression is
attributed to calponin because
the overlap with cyan is
insignificant. Vimentin
expression slightly increases 1
week post ovariectomy.
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DISCUSSION
The presented results demonstrate that 1 week following ovariectomy, there is a
significantly decreased expression of αSMA and calponin as well as a slight increase in vimentin
expression. This corresponds to muscle degeneration and fibrosis, which are both characteristic
of DU. These findings confirm that bilateral ovariectomy provides a useful model of DU, even 1
week following surgery.
In the double transgenic, untreated animal, 9.18% of the cells fluoresced both cyan and
cherry. These cells may represent myofibroblasts although the percentage of myofibroblasts in
the healthy bladder was not expected to be this high. Using a pBOO model, Bouro et al.
proposed that following bladder injury, serosal thickening is achieved in a 2 step process in
which mesenchymal cells adopt a myofibroblast phenotype first and then transition into a fetal
SMC phenotype [7]. Therefore, in the injured bladder, myofibroblasts play a crucial role in
tissue remodeling and may be more abundant following bladder injury.
The purpose of this research is to better characterize the pathogenesis and pathobiology
of DU and it was found that following ovariectomy, there is a general trend towards less
differentiated SMC. This dedifferentiation is evident in that calponin, which is a more mature
SMC marker than α-SM actin, exhibited a more pronounced decrease in expression than αSMA
1 week after ovariectomy (Calponin expression decreased 91.9 – 82.8 = 9.1 % whereas αSMA
expression decreased 21 – 14.7 = 6.3%). Similarly, vimentin, which is an early fibroblast marker
did not exhibit a significant change in expression.
It is also important to note that, especially with the endogenous fluorescence, the
percentage of cells exhibiting fluorescence of a particular fluorophore may not represent the
actual percentage of cells expressing the corresponding marker within a sample. This is
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especially evident in Figure 3 which shows that fixing cells from double transgenic samples
reduces their fluorescence by approximately 50%. Moreover, although αSMA is an earlier SMC
marker than calponin and would therefore be expressed in all SMCs that express calponin, only
21% of cells from the Sham control expressed αSMA while 91.9% expressed calponin (Figure
5). Further studies are needed to better characterize the endogenous fluorescence in transgenic
mice, as explained in “Future Directions.” Nevertheless, the change in fluorescence of each
fluorophore provides valuable information on how the expression of each marker changes.

CURRENT RESEARCH

Additional Considerations
The presented research investigated how bladder muscle stretch and a lack of estrogen
affect the bladder cellular composition. The current research investigates the effects of aging on
bladder cellular composition. Although this is a continuation of the previous study, there are
several important points and differences to consider. First, although some studies suggest aging
contributes to DU [3], a study by Brierly et al. found no correlation between DU and age [8]. In
addition to these mixed findings, the possibility of comorbidities further complicates aging
studies and care must be taken when selecting which age groups to study. Similarities are
evident between developmental and aging processes such that many of the observed
physiological changes characteristic of development are thought to occur in the opposite
direction during aging. In other words, aging may resemble dedifferentiation. Accordingly, 3
different age groups are examined during this study to include young, old, and intermediate aged
mice.
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The differences between the current research and the presented research are highlighted
in the following section. In addition to a new tissue collection and dissociation protocol, the cell
types examined and accordingly also the marker proteins employed present notable differences.
For example, in addition to SMCs and fibroblasts, the changes in the relative numbers of
urothelial cells and macrophages are also investigated. Keratin 17 is used as an urothelial protein
marker and F4/80 as a macrophage marker because it is the only well studied macrophage
marker that does not overlap in specificity with fibroblasts [9]. Moreover, fibroblast-specific
protein 1 (FSP1) is used to detect fibroblasts because it is specific for fibroblasts [10] whereas
vimentin is also expressed in myofibroblasts and fetal type SMCs [11]. Finally, αSMA is
examined through the use of immunohistochemistry rather than transgenic mice. A summary of
these markers is presented in Figure 6 and differences between this research and the presented
research are further detailed below.

Modifications in Materials and Methods
Animal care. Aged wild type female mice are acquired from the National Institute on
Aging (NIA). In total, 30 mice are ordered, such that on the date of the experiment there will be
approximately 10 each of 2 month, 12 month, and 24 month old mice.
Tissue collection and dissociation. Mice are euthanized with CO2. After saturating the
abdomen with 70% ethanol, the bladders are exposed, taking care to avoid puncturing the liver
while also excising fat and connective tissue. The bladder is held in place with forceps while a
30G1/2 needle is used to inject 250 µL dissociation solution (collagenase 2 in PBS, 2 mg/mL
final concentration) into the bladder lumen. Throughout the next 5 min, additional injections of
dissociation solution are made in different regions of the bladder between the urothelium and
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smooth muscle layer. This should require approximately 3 mL dissociation solution. Exactly 5
min after the first injection, the bladder is extracted, placed in a 60x15 mm culture dish, and
incubated at 37°C for 10 min. It is then minced with scissors in the hood and again incubated at
37°C for 5 min. The tissue sample is then gently and slowly titurated with a 1 mL pipette 10
times and again incubated at 37°C for 5 min. The tituration is repeated and the resulting cloudy
solution is filtered through a 0.2 µm cell strainer into a 50 mL falcon tube. Cold PBS is used to
wash the culture dish until the 50 mL falcon tube contains a total volume of 10 mL. This
suspension is poured into a 15 mL falcon tube and 5 mL of cold PBS is used to wash the 50 mL
falcon tube. The 15 mL falcon tube is centrifuged at 1400 RPM for 5 min. 13 mL of the
supernatant are then extracted and the primary cell pellet is resuspended using a 1 mL pipette.
15 mL of cold PBS are added to the resuspended pellet and the suspension is centrifuged as
before. 14.5 mL of the supernatant are extracted and the cell pellet is again resuspended using a
pipette. Cell count is then ascertained using 20 µL of this suspension and Trypan blue under 10x
magnification. A minimum cell density of 105 cells/mL will achieve best results.
Immunohistochemistry. Antibodies against α-SMA (Abcam – ab8211), FSP-1 (Abcam –
2795), keratin 17 (Cell Signaling – 4543), and F4/80 (ebioscience – 47-4801) are used and
conjugated to FITC (preconjugated), Alexa Fluor 680 (Invitrogen – A20172), Pacific Blue
(Invitrogen – P30013), and APC-Cy7 (preconjugated) respectively (Figure 6). As illustrated in
Figure 7, these fluorophores do not significantly overlap. Prior to staining the dissociated
bladder with these antibodies, titrations of each antibody in a cell line of each investigated type
of tissue will be conducted to determine the ideal antibody concentrations.
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Tissue

Antibody

Fluorophore

Smooth
Muscle
Fibroblast

αSMA

FITC

FSP-1

Urothelium Keratin 17

Alexa Fluor
680
Pacific Blue

Macrophage F4/80

APC-Cy7

Figure 6. Summary of Markers and Fluorophores Used to Analyze the Effects of
Aging on Bladder Cellular Composition. 4 tissue types are examined.

Sample preparation for FACS analysis & tissue characterization. Sample preparation for
FACS analysis and tissue characterization will be performed as done earlier, after first
establishing compensation controls for each of the antibodies used.

FUTURE DIRECTIONS
To strengthen these findings, the presented experiments should be repeated using larger
sample sizes. Moreover, bladders were examined 1 week post surgery and the long term impact
of bilateral ovariectomy and pBOO should also be investigated.
The changes in cellular composition accompanying bladder injury can be better
characterized by using additional marker proteins to target different cell types as well as different
levels of differentiation within a single cell type. However, in addition to financial
considerations, there are several limitations to the number of antibodies that can be used
simultaneously. First, only 3 intracellular proteins can be stained simultaneously without
obtaining interference. Furthermore, there are limits to the number of non-overlapping
fluorophores available for conjugation. Similarly, not all antibodies of interest are commercially
available. For example, although smoothelin is an ideal marker for a mature contractile SMC
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phenotype [5] and would therefore be a very valuable marker for tissue characterization, it is not
commercially available.
Studies should also be performed to better characterize the endogenous fluorescence
exhibited in transgenic mice. Endogenous fluorescence from transgenic mice may be indicative
of whether or not a particular protein is being synthesized, that is if its promoter is activated,
rather than whether or not the protein is present in the cell as is ascertained by
immunohistochemistry. The efficacy of the endogenous fluorescence as a marker can be
determined by treating tissue samples from transgenic mice with conjugated antibodies for the
marker of interest and then comparing the fluorescence from both. If the endogenous
fluorescence proves to be an adequate marker then more antibodies can be used. Plans to
complete an experiment of this nature are already forming, which is why mcherry, the
fluorophore for αSMA in the transgenic mouse model, is included in the fluorescence spectrum
(Figure 7) with the other fluorophores being used in the current aging study. If the endogenous
fluorescence is confirmed as an adequate marker for αSMA, then the fluorophore FITC could be
conjugated to another marker, such as calponin, rather than αSMA.
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Figure 7. Fluorophores Used to Analyze the Effects of Aging on Bladder Cellular Composition.
This figure was generated using the fluorescence spectrum viewer program available at
www.bdbiosciences.com and illustrates that the fluorophores being used in the aging study do not
significantly overlap. Pacific Blue is conjugated to anti-keratin 17, FITC to anti-αSMA, Alexa Fluor 680 to
an antibody against FSP-1, and APC-Cy7 to an antibody against F4/80. Although wild type mice are
used, cherry is endogenous fluorescence of αSMA and included above for future studies with transgenic
mice.

Finally, the tissue characterization techniques established throughout these experiments
can be used to analyze changes in the bladder cellular composition associated with a variety of
treatments such as current plans to demonstrate how MIF tautomerase inhibitor (ISO-1) partially
relieves bladder muscle loss and fibrosis following bilateral ovariectomy. Macrophage migration
inhibitory factor (MIF) is a cytokine that is released by the urothelium into the bladder lumen
following injury and is an essential component of the inflammation processes [12]. ISO-1 blocks
MIF by blocking its tautomerase activity. The aim of the presented research is to better
characterize DU pathophysiology and pathogenesis and further studies of ISO-1 and MIF could
therefore be very valuable because MIF is essential to the pathways responsible for the
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characteristic attributes of DU that result from bladder muscle stretch, lack of estrogen, and
aging.

CONCLUSION

1 week post ovariectomy, smooth muscle degeneration and fibrosis of the bladder are
evident. The smooth muscle degeneration resembles a dedifferentiation in which SMC
phenotypes transition towards less mature SMC phenotypes. Further studies are needed to better
characterize both the endogenous fluorescence in transgenic mice and the changes in cellular
composition of the bladder in DU pathogenesis and pathobiology.
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